Heiner Dreismann, PhD, has recently joined the HistoRx Board of Directors. As the former President and CEO of Roche Molecular Systems, Dreismann is an acknowledged diagnostic industry expert.

Dreismann was with Hoffmann La Roche for 20 years serving in several roles, including Head of Global Business Development Roche Diagnostics, Head of PCR Business Unit for Europe, President and CEO of Roche Molecular Systems, and member of the global Executive Committee of Roche Diagnostics.

HistoRx CEO Rana K. Gupta said, "As we reach the commercialization stage of our diagnostics portfolio it’s important to add knowledgeable experts from the global distribution companies that have brought new technologies forward to labs around the world. Heiner’s experience with the launch and market development of PCR, and his familiarity with key decision makers across the diagnostics industry make him a valuable addition to the HistoRx Board."

"I am pleased to join the board of directors of HistoRx, a company that has developed a unique and innovative technology to address the key unmet need of the pathology community," Dreismann said. "HistoRx products have great potential in the United States and overseas markets."

Source: HistoRx Inc